Table 2.
KEGG biological pathways for differentially expressed genes
| KEGG pathway | Probed* | Observed | Expected | FDR |
| Regulation of actin cytoskeleton (RAC) | 204 | 76 | 36.99 | 4.71e-09 |
| Cell adhesion molecules (CAMs) | 127 | 51 | 23.03 | 1.63e-07 |
| Focal adhesion (FA) | 208 | 72 | 37.71 | 1.98e-07 |
| Natural killer cell mediated cytotoxicity (NK) | 127 | 47 | 23.03 | 5.94e-06 |
| Leukocyte transendothelial migration (LTEM) | 115 | 43 | 20.85 | 1.06e-05 |
| Type I diabetes mellitus (T1DM) | 42 | 20 | 7.62 | 1.29e-04 |
| ECM-receptor interaction (ECM) | 86 | 31 | 15.59 | 5.69e-04 |
| T cell receptor signaling pathway (T cell) | 99 | 34 | 17.95 | 6.93e-04 |
| Hematopoietic cell lineage (HCL) | 84 | 30 | 15.23 | 7.03e-04 |
| B cell receptor signaling pathway (B cell) | 70 | 26 | 12.69 | 8.65e-04 |
| Adherens junction (AJ) | 76 | 27 | 13.78 | 1.38e-03 |
| Gap junction (GJ) | 96 | 32 | 17.41 | 1.38e-03 |
| Calcium signaling pathway (Ca2+) | 175 | 50 | 31.73 | 2.12e-03 |
| Antigen processing and presentation (AP&P) | 79 | 27 | 14.32 | 2.12e-03 |
| Cytokine-cytokine receptor interaction (CCRI) | 247 | 66 | 44.78 | 2.12e-03 |
| Tight junction (TJ) | 116 | 36 | 21.03 | 2.12e-03 |
| Alzheimer's disease (AD) | 22 | 11 | 3.99 | 2.60e-03 |
| MAPK signaling pathway (MAPK) | 270 | 69 | 48.95 | 5.10e-03 |
| Long-term potentiation (LTP) | 68 | 21 | 12.33 | 2.58e-02 |
| Wnt signaling pathway (WNT) | 144 | 38 | 26.11 | 2.87e-02 |
| Axon guidance (AG) | 129 | 34 | 23.39 | 4.02e-02 |
* Probed indicates the number of genes with a membership in a particular pathway and for which probes were available on both microarray platforms.